New Delhi, Oct 30
Novartis India today reported 15.78 per cent rise in net profit to Rs 45.55 crore for the quarter ended September 30, on the back of a favourable ruling in a dispute that resulted in higher tax cr...
New Delhi, Aug 28
Tearing into the allegations made by Novartis on India’s ‘discriminatory’ patent practices, the Government has said global firms, including the Swiss drug major, have benefited more from the count...
Mumbai, July 24
Drug-maker Novartis said that its profit after tax dipped by 49 per cent at Rs 13.9 crore for the first quarter ended June 30 compared with Rs 27 crore in the corresponding period...
Mumbai, July 13
Three students from Jamshedpur, Mangalore and Delhi would represent India at Novartis’ International BioCamp at Basel, Switzerland. Jamshedpur student Shreetam Subhrankar is an alum...
New Delhi, Jun 28
Drug firm Novartis India today said its parent Novartis AG has offloaded 1.42 per cent stake in it through open market for a consideration of over Rs 25 crore to meet market regulator SEBI guideli...
New Delhi, May 14
Drug firm Novartis India today reported a 25.82 per cent dip in its net profit to Rs 24.41 crore for the quarter ended March 31, 2013 as compared to the corresponding period in the previous fiscal...
May 14, 2013
Novartis India Ltd has informed BSE about the Financial Results & a copy of Results Press Release for the period ended March 31, 2013.
Source : BSE - »
May 9, 2013
With reference to earlier announcement dated March 28, 2013 regarding proposed reduction of promoter’s shareholding in the Company through the Stock Exchange mechanism, Further, Novartis India Ltd...
November 1, 2013
Novartis India Ltd has informed BSE regarding a Press Release dated October 30, 2013 titled "Novartis India Announces Results for the Quarter and Half-Year ended 30 September 2013"
October 30, 2013
Novartis India Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended Sept 30, 2013.
Source : BSE - »
New Delhi, Aug 18
Hitting out at India’s way of dealing with Intellectual Property Rights (IPR) issues, drug major Novartis has said India is losing investments in research and development from MNCs to China due to...
Geneva, July 17
A bonanza payout to the former chairman of Novartis has been cut back radically, the pharmaceutical group said on Wednesday, reporting also a fall in second quarter profit.
The golden han...
New Delhi, July 8
Switzerland-based drug major Novartis has entered into a development and licensing agreement with Biological E (BioE) for vaccines against typhoid and paratyphoid fevers.Under the licence,...
Mumbai, June 11
Multinational drug-maker Novartis is undertaking an investigation into unethical practices around the promotion of its diabetes drug Galvus, in india.
The company reporte...
May 14, 2013
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has considered and approved the following:
- Dividend recomm...
Mumbai, May 13
Novartis India has announced the next edition of the Novartis Biotechnology Leadership Camp (BioCamp) taking place in Hyderabad from July 8-10, 2013.
BioCamp is a seminar orga...
April 12, 2013
Proposed clauses in the EU-India FTA could undo all gains from the Supreme Court’s Glivec ruling. »